Options Brief: Dynavax Technologies

Shares of Dynavax Technologies DVAX are higher on the session by 24.28%, trading at $3.02. Overall call volume is now running at 23.31x the daily average, with 19% of all calls traded being purchases on the offer. 2,508 contracts have traded on the session so far. Dynavax Technologies Corporation is a biopharmaceutical company that discovers and develops products to prevent and treat infectious diseases, asthma and inflammatory and autoimmune diseases.